Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Schrodinger Inc
(NQ:
SDGR
)
23.68
+0.49 (+2.11%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Schrodinger Inc
< Previous
1
2
3
4
Next >
Schrödinger Reports First Quarter 2024 Financial Results
May 01, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 18, 2024
From
Schrödinger
Via
Business Wire
Schrödinger to Announce First Quarter 2024 Financial Results on May 1
April 10, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting
March 20, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 19, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Strong Fourth Quarter and Full-Year 2023 Financial Results
February 28, 2024
From
Schrödinger
Via
Business Wire
Schrödinger to Participate in Upcoming Investor Conferences
February 20, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
February 16, 2024
From
Schrödinger
Via
Business Wire
Schrödinger to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28
February 14, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
January 19, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Provides Update on Progress Across the Business and Outlines 2024 Development and Operational Goals
January 08, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
December 19, 2023
From
Schrödinger
Via
Business Wire
Schrödinger Highlights Progress of Clinical Programs and Discloses Three New Programs at First Therapeutics Pipeline Investor Event
December 14, 2023
From
Schrödinger
Via
Business Wire
Schrödinger Presents Data Supporting Advancement of SGR-1505 and SGR-2921 at American Society of Hematology 2023 Annual Meeting
December 10, 2023
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
November 17, 2023
From
Schrödinger
Via
Business Wire
Schrödinger to Participate in Upcoming Investor Conferences
November 06, 2023
From
Schrödinger
Via
Business Wire
Schrödinger to Present New Data for SGR-1505 and SGR-2921 at American Society of Hematology 2023 Annual Meeting
November 02, 2023
From
Schrödinger
Via
Business Wire
Schrödinger Reports Third Quarter 2023 Financial Results
November 01, 2023
From
Schrödinger
Via
Business Wire
Schrödinger to Host Pipeline Day on December 14, 2023
October 30, 2023
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
October 23, 2023
From
Schrödinger
Via
Business Wire
Schrödinger to Announce Third Quarter 2023 Financial Results on November 1
October 18, 2023
From
Schrödinger
Via
Business Wire
Schrödinger and Two City University of New York Colleges Awarded $1M NSF Grant to Increase Access to Computational Molecular Modeling Education
September 28, 2023
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
September 18, 2023
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger to Present at Morgan Stanley Global Healthcare Conference
September 05, 2023
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
August 11, 2023
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Reports Second Quarter 2023 Financial Results
August 02, 2023
From
Schrödinger, Inc.
Via
Business Wire
Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist
August 01, 2023
Artificial intelligence (AI) has hit the mainstream with fervor. Specifically, generative AI has gone viral with the explosion in ChatGPT users.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Biotech & Healthcare Meet AI: Stocks Soar On Innovation Potential
July 28, 2023
A growing number of companies in the biotech and healthcare industries are using AI to revolutionize drug discovery and patient care, leading to stock surges.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Exscientia is the Sniper of the AI Drug Discovery Industry
July 27, 2023
News of a $50 million investment by artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA) into AI-powered drug discovery company Recursion
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 20, 2023
From
Schrödinger, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.